Sonographic risk stratification of FDG‐avid thyroid nodules using the Thyroid Imaging Reporting and Data System

Tianchi Ren,Ilona Lavender,Peter Coombs,Dee Nandurkar

DOI: https://doi.org/10.1111/1754-9485.13712

2024-05-29

Journal of Medical Imaging and Radiation Oncology

Abstract:Introduction The increasing usage of positron emission tomography/computed tomography (PET/CT) for detection and monitoring of malignancy has led to an increase in incidental detection of thyroid nodules. Nodules that demonstrate increased avidity for 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose (FDG) have been shown to carry a high incidence of malignancy and warrant further investigation. At present, there has been limited research on the risk stratification of FDG‐avid thyroid incidentalomas. Thus, this study aims to evaluate the efficacy of the ACR TIRADS classification in the risk stratification of such nodules. Methods Data were collected retrospectively for FDG‐avid thyroid incidentalomas over a 10‐year period. Nodules were characterised using the TIRADS classification and, subsequently, underwent fine‐needle aspirate cytology. Cytological findings were classified using the Bethesda reporting system. Non‐diagnostic samples (Bethesda class I) were excluded. The remaining samples were divided into two groups: benign (Bethesda class II) or suspicious for malignancy/malignant (Bethesda class III or above). Results Thirty‐six percent of low‐risk nodules and 45% of high‐risk nodules were malignant, respectively (P = 0.516). The sensitivity and specificity of TIRADS for detection of malignant nodules were 56% and 54%, respectively. There were no malignant TIRADS 1 or 2 nodules. The absence of any suspicious sonographic features had a 1.0 negative predictive value. Conclusions FDG‐avid nodules classified as TIRADS 1 or 2 or have no suspicious ultrasound features have a 0% incidence of malignancy and thus may not require further assessment with fine‐needle aspirate cytology (FNA) when detected incidentally. FDG‐avid nodules that are TIRADS 3 or above should undergo FNA regardless of size due to the high risk of malignancy and poor sensitivity of the TIRADS classification system.

radiology, nuclear medicine & medical imaging